A Prospective Phase II Trial of First-line Osimertinib for Patients with EGFR Mutation-positive Non-small Cell Lung Cancer and Poor Performance Status (OPEN/TORG2040)
Journal of Thoracic Oncology（2025）
关键词
Osimertinib,EGFR,Non-small cell lung cancer,Poor performance status,Quality of life
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要